The following is a summary of “Clinical remission attainment, definitions, and correlates among patients with severe asthma ...

Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

A year ago, he became one of just 200 people selected to take part in the trial of a new asthma treatment, Benralizumab, that ...

“The current treatment landscape for severe asthma has made significant strides, particularly for T2-high asthma. There is an urgent need for both reliable biomarkers and therapies targeting ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

Researchers have unveiled a groundbreaking nasal swab test for diagnosing specific asthma endotypes in children, particularly ...

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Early-life infection burden is associated with an increased risk for later moderate-to-severe infections and systemic ...